Coronavirus Vaccinations
-
{
- All
- News
-
Breakthrough: Universal Coronavirus Vaccine Designed By AI Passes Human Trial
- Sunday June 7, 2026
- Health | Written by Rupashi Chhabra
Scientists have successfully tested an AI-designed universal coronavirus vaccine in humans. Here is how this needle-free super-antigen aims to future-proof humanity against all future mutations.
-
www.ndtv.com/health
-
Artificial Intelligence Creates Vaccine Aimed At Preventing Future Pandemics
- Friday June 5, 2026
- Science | Edited by Astitva Raj
Researchers say the technology has already been used to create and test a vaccine designed to protect against multiple coronaviruses.
-
www.ndtv.com
-
Universal Coronavirus Vaccine? New Jab Targets Even Unknown Threats
- Wednesday May 8, 2024
- Science | Edited by Nikhil Pandey
Researchers have made a new coronavirus vaccine that could also protect against viruses we haven't found yet, to stop future pandemics.
-
www.ndtv.com
-
Dr.Reddy's Says Sputnik V Covid-19 Vaccine Safe In India Mid-stage Trial
- Friday December 8, 2023
- Author: Edited by Nirmalya Sen
The company has submitted the mid-stage trial safety data to India's drug regulator for review and approval to continue late-stage trials
-
www.ndtvprofit.com
-
Dr.Reddy's Says Sputnik V Covid-19 Vaccine Safe In India Mid-stage Trial
- Friday December 8, 2023
- Author: Edited by Nirmalya Sen
The company has submitted the mid-stage trial safety data to India's drug regulator for review and approval to continue late-stage trials
-
www.ndtvprofit.com
-
COVID-19: Vaccine Makers Face Biggest Medical Manufacturing Feat In History
- Thursday December 7, 2023
- Author: Reuters
The supply chain of a potential vaccine stretches from Pune in India to England's Oxford and Baltimore in the United States
-
www.ndtvprofit.com
-
Serum Institute Seeks Inclusion Of Covid Jab 'Covovax' In CoWIN Portal
- Wednesday January 18, 2023
- India News | Press Trust of India
Serum Institute of India has written to the Union Health Ministry seeking the inclusion of its Covid vaccine Covovax in the CoWIN portal as a heterologous booster dose for adults, official sources said on Wednesday.
-
www.ndtv.com
-
Centre's Panel Recommends Market Clearance To Covovax As Covid Booster: Report
- Thursday January 12, 2023
- India News | Press Trust of India
An expert panel of the central drug regulatory authority has recommended market authorisation for Serum Institute of India's Covid vaccine Covovax as a heterologous booster dose for adults, Press Trust of India reported.
-
www.ndtv.com
-
'Bivalent' Booster For Omicron, Original Covid Strain Approved By UK
- Saturday September 3, 2022
- World News | Press Trust of India
The UK health authorities on Saturday approved a second "bivalent" vaccine to be used as a booster vaccine to target both the Omicron and original strain of COVID-19.
-
www.ndtv.com
-
India's Covid Vaccination Coverage Exceeds 196.94 Crore: Health Ministry
- Saturday June 25, 2022
- India News | Asian News International
India's cumulative COVID-19 vaccination coverage exceeded the 196.94 crores (1,96,94,40,932) mark today, informed the Ministry of Health and Family Welfare.
-
www.ndtv.com
-
US Approves Covid Vaccine For Children 6 Months And Above
- Friday June 17, 2022
- World News | Agence France-Presse
The US Food and Drug Administration granted emergency authorization Friday for the use of Pfizer and Moderna Covid-19 vaccines in the youngest children, the final age group awaiting immunization in most countries.
-
www.ndtv.com
-
"Covaxin Safe For Kids Aged 2-18": Here's What Bharat Biotech Says On Side-Effects
- Friday June 17, 2022
- India News | Reported by Parimal Kumar, Edited by Aarish Chhabra
Data on Covaxin for children has been published online in The Lancet Infectious Diseases journal on June 16
-
www.ndtv.com
-
EU Watchdog Reviews Adapted Pfizer Jab. Target: Omicron
- Wednesday June 15, 2022
- World News | Agence France-Presse
Europe's medicines watchdog said Wednesday it has started to review an adapted version of Pfizer/BioNTech's anti-Covid jab in order to better protect against specific variants of the virus, including Omicron.
-
www.ndtv.com
-
Breakthrough: Universal Coronavirus Vaccine Designed By AI Passes Human Trial
- Sunday June 7, 2026
- Health | Written by Rupashi Chhabra
Scientists have successfully tested an AI-designed universal coronavirus vaccine in humans. Here is how this needle-free super-antigen aims to future-proof humanity against all future mutations.
-
www.ndtv.com/health
-
Artificial Intelligence Creates Vaccine Aimed At Preventing Future Pandemics
- Friday June 5, 2026
- Science | Edited by Astitva Raj
Researchers say the technology has already been used to create and test a vaccine designed to protect against multiple coronaviruses.
-
www.ndtv.com
-
Universal Coronavirus Vaccine? New Jab Targets Even Unknown Threats
- Wednesday May 8, 2024
- Science | Edited by Nikhil Pandey
Researchers have made a new coronavirus vaccine that could also protect against viruses we haven't found yet, to stop future pandemics.
-
www.ndtv.com
-
Dr.Reddy's Says Sputnik V Covid-19 Vaccine Safe In India Mid-stage Trial
- Friday December 8, 2023
- Author: Edited by Nirmalya Sen
The company has submitted the mid-stage trial safety data to India's drug regulator for review and approval to continue late-stage trials
-
www.ndtvprofit.com
-
Dr.Reddy's Says Sputnik V Covid-19 Vaccine Safe In India Mid-stage Trial
- Friday December 8, 2023
- Author: Edited by Nirmalya Sen
The company has submitted the mid-stage trial safety data to India's drug regulator for review and approval to continue late-stage trials
-
www.ndtvprofit.com
-
COVID-19: Vaccine Makers Face Biggest Medical Manufacturing Feat In History
- Thursday December 7, 2023
- Author: Reuters
The supply chain of a potential vaccine stretches from Pune in India to England's Oxford and Baltimore in the United States
-
www.ndtvprofit.com
-
Serum Institute Seeks Inclusion Of Covid Jab 'Covovax' In CoWIN Portal
- Wednesday January 18, 2023
- India News | Press Trust of India
Serum Institute of India has written to the Union Health Ministry seeking the inclusion of its Covid vaccine Covovax in the CoWIN portal as a heterologous booster dose for adults, official sources said on Wednesday.
-
www.ndtv.com
-
Centre's Panel Recommends Market Clearance To Covovax As Covid Booster: Report
- Thursday January 12, 2023
- India News | Press Trust of India
An expert panel of the central drug regulatory authority has recommended market authorisation for Serum Institute of India's Covid vaccine Covovax as a heterologous booster dose for adults, Press Trust of India reported.
-
www.ndtv.com
-
'Bivalent' Booster For Omicron, Original Covid Strain Approved By UK
- Saturday September 3, 2022
- World News | Press Trust of India
The UK health authorities on Saturday approved a second "bivalent" vaccine to be used as a booster vaccine to target both the Omicron and original strain of COVID-19.
-
www.ndtv.com
-
India's Covid Vaccination Coverage Exceeds 196.94 Crore: Health Ministry
- Saturday June 25, 2022
- India News | Asian News International
India's cumulative COVID-19 vaccination coverage exceeded the 196.94 crores (1,96,94,40,932) mark today, informed the Ministry of Health and Family Welfare.
-
www.ndtv.com
-
US Approves Covid Vaccine For Children 6 Months And Above
- Friday June 17, 2022
- World News | Agence France-Presse
The US Food and Drug Administration granted emergency authorization Friday for the use of Pfizer and Moderna Covid-19 vaccines in the youngest children, the final age group awaiting immunization in most countries.
-
www.ndtv.com
-
"Covaxin Safe For Kids Aged 2-18": Here's What Bharat Biotech Says On Side-Effects
- Friday June 17, 2022
- India News | Reported by Parimal Kumar, Edited by Aarish Chhabra
Data on Covaxin for children has been published online in The Lancet Infectious Diseases journal on June 16
-
www.ndtv.com
-
EU Watchdog Reviews Adapted Pfizer Jab. Target: Omicron
- Wednesday June 15, 2022
- World News | Agence France-Presse
Europe's medicines watchdog said Wednesday it has started to review an adapted version of Pfizer/BioNTech's anti-Covid jab in order to better protect against specific variants of the virus, including Omicron.
-
www.ndtv.com